View in EDS

A Phase 1 Open-Label Study Assessing the Safety and Pharmacokinetics of TV-46000, an Extended-Release Injectable Suspension of Risperidone for Subcutaneous Use.

Saved in:
Bibliographic Details
Title: A Phase 1 Open-Label Study Assessing the Safety and Pharmacokinetics of TV-46000, an Extended-Release Injectable Suspension of Risperidone for Subcutaneous Use.
Authors: Merenlender Wagner A; Teva Pharmaceutical Industries Ltd., Quantitative Pharmacology and Biosimilar Sciences, 12 Hatrufa Street, 42504, Netanya, Israel. Avia.MerenlenderWagner@teva.co.il., Perlstein I; Magic Wand Research LLC, Philadelphia, PA, USA., Farkas P; Teva PLIVA Croatia Ltd, Research and Development, Zagreb, Croatia., Lamson M; Nuventra Pharma Sciences, Pharmacokinetics and Clinical Pharmacology, Carrboro, NC, USA., Loupe P; Teva Branded Pharmaceutical Products LLC, West Chester, PA, USA., Spiegelstein O; Teva Pharmaceutical Industries Ltd., Quantitative Pharmacology and Biosimilar Sciences, 12 Hatrufa Street, 42504, Netanya, Israel., Kalmanczhelyi A; Teva Pharmaceutical Works Private Ltd., Debrecen, Hungary., Tiver R; Teva Branded Pharmaceutical Products LLC, West Chester, PA, USA., Franzenburg KR; Teva Branded Pharmaceutical Products LLC, West Chester, PA, USA., Harary E; Teva Pharmaceutical Industries Ltd., Quantitative Pharmacology and Biosimilar Sciences, 12 Hatrufa Street, 42504, Netanya, Israel., Elgart A; Teva Pharmaceutical Industries Ltd., Quantitative Pharmacology and Biosimilar Sciences, 12 Hatrufa Street, 42504, Netanya, Israel.
Source: CNS drugs [CNS Drugs] 2026 Aug; Vol. 40 (8), pp. 1165-1177. Date of Electronic Publication: 2026 Jun 15.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42295697
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase 1 Open-Label Study Assessing the Safety and Pharmacokinetics of TV-46000, an Extended-Release Injectable Suspension of Risperidone for Subcutaneous Use.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Merenlender+Wagner+A%22">Merenlender Wagner A</searchLink>; Teva Pharmaceutical Industries Ltd., Quantitative Pharmacology and Biosimilar Sciences, 12 Hatrufa Street, 42504, Netanya, Israel. Avia.MerenlenderWagner@teva.co.il.<br /><searchLink fieldCode="AU" term="%22Perlstein+I%22">Perlstein I</searchLink>; Magic Wand Research LLC, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Farkas+P%22">Farkas P</searchLink>; Teva PLIVA Croatia Ltd, Research and Development, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Lamson+M%22">Lamson M</searchLink>; Nuventra Pharma Sciences, Pharmacokinetics and Clinical Pharmacology, Carrboro, NC, USA.<br /><searchLink fieldCode="AU" term="%22Loupe+P%22">Loupe P</searchLink>; Teva Branded Pharmaceutical Products LLC, West Chester, PA, USA.<br /><searchLink fieldCode="AU" term="%22Spiegelstein+O%22">Spiegelstein O</searchLink>; Teva Pharmaceutical Industries Ltd., Quantitative Pharmacology and Biosimilar Sciences, 12 Hatrufa Street, 42504, Netanya, Israel.<br /><searchLink fieldCode="AU" term="%22Kalmanczhelyi+A%22">Kalmanczhelyi A</searchLink>; Teva Pharmaceutical Works Private Ltd., Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Tiver+R%22">Tiver R</searchLink>; Teva Branded Pharmaceutical Products LLC, West Chester, PA, USA.<br /><searchLink fieldCode="AU" term="%22Franzenburg+KR%22">Franzenburg KR</searchLink>; Teva Branded Pharmaceutical Products LLC, West Chester, PA, USA.<br /><searchLink fieldCode="AU" term="%22Harary+E%22">Harary E</searchLink>; Teva Pharmaceutical Industries Ltd., Quantitative Pharmacology and Biosimilar Sciences, 12 Hatrufa Street, 42504, Netanya, Israel.<br /><searchLink fieldCode="AU" term="%22Elgart+A%22">Elgart A</searchLink>; Teva Pharmaceutical Industries Ltd., Quantitative Pharmacology and Biosimilar Sciences, 12 Hatrufa Street, 42504, Netanya, Israel.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229431220%22">CNS drugs</searchLink> [CNS Drugs] 2026 Aug; Vol. 40 (8), pp. 1165-1177. <i>Date of Electronic Publication: </i>2026 Jun 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9431220 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1934 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211727047%22">11727047 </searchLink><i>NLM ISO Abbreviation: </i>CNS Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42295697
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40263-026-01302-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1165
    Titles:
      – TitleFull: A Phase 1 Open-Label Study Assessing the Safety and Pharmacokinetics of TV-46000, an Extended-Release Injectable Suspension of Risperidone for Subcutaneous Use.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Merenlender Wagner A
      – PersonEntity:
          Name:
            NameFull: Perlstein I
      – PersonEntity:
          Name:
            NameFull: Farkas P
      – PersonEntity:
          Name:
            NameFull: Lamson M
      – PersonEntity:
          Name:
            NameFull: Loupe P
      – PersonEntity:
          Name:
            NameFull: Spiegelstein O
      – PersonEntity:
          Name:
            NameFull: Kalmanczhelyi A
      – PersonEntity:
          Name:
            NameFull: Tiver R
      – PersonEntity:
          Name:
            NameFull: Franzenburg KR
      – PersonEntity:
          Name:
            NameFull: Harary E
      – PersonEntity:
          Name:
            NameFull: Elgart A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2026 Aug
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1934
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: CNS drugs
              Type: main
ResultId 1